Obstructive Lung Diseases Completed Phase 3 Trials for Esomeprazole (DB00736)

Also known as: Obstructive Lung Disease / Lung Disease,Obstructive / Lung Disease, Obstructive / Lung Diseases, Obstructive

IndicationStatusPhase
DBCOND0068721 (Obstructive Lung Diseases)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00069823Study of Acid Reflux in AsthmaTreatment